The effect of high-intensity interval training (HIIT) on SYD and MuRF1 gene expression of in diabetic rats

Authors
ahmad jafari 1
mozhgan ahmadi 2
saeedeh shadmehri 2
1 Department Sport physiology, Yadegar-e-Imam Khomeini (RAH) Shahre-rey Branch, Islamic Azad University, Tehran, Iran
2 Department of Physical Education and Sport Science, Yadegar-e-Imam Khomeini (RAH) Shahre-rey Branch, Islamic Azad University, Tehran, Iran
Abstract
Introduction

Syd and Murf1 are important molecular markers for muscle atrophy that increase significantly in skeletal muscle in various conditions, such as diabetes. The aim of this study was to evaluate the effect of high-intensity interval training (HIIT) on syd and murf1 genes expression in skeletal muscle of diabetic rats.

Materials and Methods

To the implementation of this experimental research, 60 male Wistar rats weighing 220 ± 20 gr randomly were divided into 5 groups including baseline control, eight-week control, diabetes, training, and diabetes-training. In this study, the rats were diabetic using given a single dose of 50 mg/ kg per body weight and peritoneal injection streptozotocin. High-intensity interval training performed on the treadmill with intensity of 80-85% VO2max, 5 days a week and for 8 weeks. The expression of syd and murf1 genes were measured by Real-Time PCR. Data were analyzed by one-way ANOVA and Bonferroni's post hoc test at the p<0.05.

Results

The changes in the expression of Murf1 and Syd genes of the skeletal muscle in the diabetes group were significantly higher than the control group (P=0.001). The high-intensity interval training significantly reduced the expression of Murf1 and Syd genes (P=0.001).

Conclusion

HIIT may help reduce atrophy in diabetic patients by reducing the expression of syd and murf1 genes in skeletal muscle.
Keywords
Keywords Diabetes
SYD
High-intensity interval training
MuRF1
1. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24(5):816-23.
2. Le NH, Kim CS, Park T, Park JH, Sung MK Lee DG, et al. Quercetin protects against obesity-induced skeletal muscle inflammation and atrophy. Mediators Inflamm 2014; 2014: 834294.
3. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014; 2: 819–29.
4. Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 2015; 14(1):58–74.
5. Lambertucci AC, Lambertucci RH, Hirabara SM, Curi R, Moriscot AS, Alba-Loureiro TC, et al. Glutamine supplementation stimulates protein-synthetic and inhibits protein-degradative signaling pathways in skeletal muscle of diabetic rats. PLoS One 2012; 7(12): e50390.
6. Hulmi JJ, Silvennoinen M, Lehti M, Kivela R, Kainulainen H. Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin- induced diabetic muscle atrophy. Am J Physiol Endocrinol Metab 2012; 302(3): E307–15.
7. Sandri M. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol 2013; 45(10):2121–9.
8. Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 2006; 17(7):1807–1819.
9. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteaso-mal pathways in atrophying muscle cells. Cell Metab 2007; 6(6):472–83.
10. Perry BD, Caldow MK, Brennan-Speranza TC, Sbaraglia M, Jerums G, Garnham, A, et al. Muscle atrophy in patients with Type 2 diabetes mellitus: roles of inflammatory pathways, physical activity and exercise. Exerc Immunol Rev 2016; 22, 94–109.
11. Schulman VK, Folker ES, Rosen JN, Baylies MK. Syd/JIP3 and JNK signaling are required for myonuclear positioning and muscle function. PLoS Genet 2014;10(12): e1004880.
12. Folker ES, Baylies MK. Nuclear positioning in muscle development and disease. Front Physiol 2013; 4: 363.
13. Fouladvand M, Gharakhanlou R, Hematfar A, Rahmati M. The Effect of endurance training on SYD gene expression in motor neurons of rats with diabetic neuropathy. Journal of Sport Biosciences 2017; 8(4): 480-65. [Persian]
14. Panahi S, Agha-Alinejad H, Gharakhanloo R, Fayazmilani R, Hedayati M, Safarzadeh A, et al. The effect of 4 weeks resistance training on Murf1 gene expression and muscle atrophy in diabetic wistar rats. tbzmed 2016; 38(2):6-13. [Persian]
15. Liu HW, Sue-Joan C. Moderate exercise suppresses NF-κB signaling and activates the SIRT1-AMPK-PGC1α axis to attenuate muscle loss in diabetic db/db mice. Front Physio 2018;29(9): 636.
16. Ribeiro MBT, Guzzoni V, Hord JM, Lopes GN, Marqueti RC, Andrade RV, et al. Resistance training regulates gene expression of molecules associated with intramyocellular lipids, glucose signaling and fiber size in old rats. Sci Rep 2017; 7: 8593.
17. da Silva DE, Grande AJ, Roever L, Tse G, Liu T, Biondi-Zoccai G, de Farias JM. High-intensity interval training in patients with type 2 diabetes mellitus: a systematic review. Curr Atheroscler Rep 2019 2;21(2):8.
18. Wormgoor SG, Dalleck LC, Zinn C, Harris NK. Effects of High-Intensity Interval Training on People Living with Type 2 Diabetes: A Narrative Review. Can J Diabetes 2017; 41(5):536-47.
19. Gibala M J, Little J P, Macdonald M J, Hawley J A. Physiological adaptations to lowvolume, high-intensity interval training in health and disease. J Physiol 2012; 590 (5):1077-84.
20. Shirwaikar A, Rajendran K, Barik R. Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced type-II diabetes mellitus. J Ethnopharmacol 2006; 107 (2): 285-90
21. Aghaei F, Mohsenzadeh M. The effect of high intensity interval training on retinol binding protein 4 and AMP-activated protein kinase gene expression in skeletal muscle of rats with type ii diabetes. Armaghane danesh 2019; 23(6):709-1.
22. Junyent F, Verdaguer E, Folch J, Beas-Zarate C, Pallàs M, Auladell C, et al. Role of JNK in neurodegenerative diseases. Recent Advances in Pharmaceutical Sciences II 2012; 37(2): 15-28
23. Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, et al. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 2007; 6(5): 376-85.
24. Centeno C, Repici M, Chatton JY, Riederer BM, Bonny C, Nicod P, et al. Role of the JNK pathway in NMDA-mediatedxcitotoxicity of cortical neurons. Cell Death Differ 2007; 14(2):240-53.
25. Antoniou X, Falconi M, Di Marino D, Borsello T. JNK3 as a therapeutic target for neurodegenerative diseases. J Alzheim Dis 2011; 24(4):633–42.
26. Kelleher AR, Fairchild TJ, Keslacy S. STZ-induced skeletal muscle atrophy is associated with increased p65 content and downregulation of insulin pathway without NF-kappaB canonical cascade activation. Acta Diabetol 2010; 47(4): 315-23.
27. Chen GQ, Mou CY, Yang YQ, Wang S, Zhao ZW. Exercise training has beneficial anti-atrophy effects by inhibiting oxidative stress-induced MuRF1 upregulation in rats with diabetes. Life Sci 2011; 89(2): 44-9.
28. Mastrocola R, Reffo P, Penna F, Tomasinelli CE, Boccuzzi G, Baccino FM, et al. Muscle wasting in diabetic and in tumor bearing rats: role of oxidative stress. Free Radic Biol Med 2008; 44(4):584- 93.
29. Sheibani S, daryanoosh F, salesi M, koushkie jahromi M, tanideh N. The effect of high-intensity training and detraining on FOXO3a/MuRF1 and MAFbx levels in soleus muscle of male rats. EBNESINA- Journal of Medical. 2018; 20 (1) :31-9. [Persian]
30. Ato S, Makanae Y, Kido K, Fujita S. Contraction mode itself does not determine the level of mTORC1 activity in rat skeletal muscle. Physiol Rep 2016; 4(19):1–11.
31. Holloway TM, Bloemberg D, da Silva ML, Simpson JA, Quadrilatero J, Spriet LL. High intensity interval and endurance training have opposing effects on markers of heart failure and cardiac remodeling in hypertensive rats. PloS One. 2015; 10(3):1–16.
32. Gharakhanlou R, Fouladvand M, Hematfarorcid A, Rahmati M. Modulation of SYD gene expression in sensory neurons of rats with diabetic neuropathy following endurance training. Ijdld. 2013; 12(4):292-301. [Persian]
33. Karami Paskohani A, Rahmati M, Kazemi A. modulation of sundaydrivergene expression in soleus muscle of rats with diabetic neuropathy following endurance training. ijdld. 2016; 14 (3) :169-78. [Persian]
34. Cassidy S, Thoma C, Houghton D, Trenell MI. High-intensity interval training: a review of its impact on glucose control and cardiometabolic health. Diabetologia 2017; 60(1):7-23.
35. Bowman AB, Kamal BW, Richtings A, Philp M, McGrail JG, Gindhardt LSB. Kinesin-dependent axonal transport is mediated by the Sunday driver(SYD) protein. Cell 2000; 103(4):583-94.
36. Cavalli V, Kujala P, Klumperman J, Goldstein LS. Sunday Driver links axonal transport to damage signaling. J Cell Biol 2005; 168(5):775–87.
Journal of Netshabur University of Medical Sciences
Volume 7, Issue 3 - Serial Number 24
Summer 2019
Pages 119-130